Recent findings about the heterosexual transmission of HIV and AIDS

Current Opinion in Infectious Diseases

Volumn 11, Issue 1, 1998, Pages 9-12

  Padian, Nancy S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CHEMOKINE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CELLULAR IMMUNITY; CONTRACEPTION; GENETIC PREDISPOSITION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR BIOLOGY; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; SHORT SURVEY; VIRUS TRANSMISSION;

EID: 0031985612     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-199802000-00003     Document Type: Short Survey

References (28)

1. Neal J, Fleming P, Green T, Ward J. Trends in heterosexually acquired AIDS in the United States, 1988 through 1995. J AIDS 1997; 14:465-474. This is a comprehensive review of trends in AIDS cases over the past few years. Because no such nation-wide data exist with regard to HIV, this represents the most complete analysis of the available data.
2. Centers for Disease Control. HIV/AIDS Surveillance Reports; 1997; 9:3-39.
3. Padian N, Shiboski S, Glass S, Vittinghoff E. Heterosexual transmission of human immuodeficieny virus (HIV) in Northern California: results from a ten-year study. Am J Epidemiol 1997; 146:350-357. This paper summarizes cross-sectional and longitudinal results from the longest and largest study of heterosexual transmission in the USA.
4. Deschamps M, Pape J, Hafner A, Johnson W. Heterosexual transmission of HIV in Haiti. Ann Intern Med 1996; 125:324-330. This study is one of the largest prospective studies of discordant couples, in which investigators were able to report reliable estimates of incidence and associated risk factors.
5. Guimares M, Vlahov D, Castilho E. Postcoital vaginal bleeding as a risk factor for transmission of the human immunodeficiency virus in heterosexual partners in Brazil. Arch Intern Med 1997; 157:1363-1368.
6. Urassa M, Todd J, Boerma J, Hayes R, Isingo R. Male circumcision and susceptibility to HIV infection among men in Tanzania. AIDS 1997; 11:73-80.
7. Robinson N, Mulder D, Auvert B, Hayes R. Proportion of HIV infections attributable to other sexually transmitted diseases in a rural Ugandan population: simulation model estimates, Int J Epidemiol 1997; 26:180-189.
8. Sewankambo N, Gray R, Wawer M, Paxton L, McNaim D, Wabwire-Mangen F, et al. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 1997; 350:546-550.
9. Royce R, Sena A, Cates W, Cohen M. Sexual transmission of HIV. N Engl J Med 1997; 336:1072-1078.
10. Marx P, Spira A, Gettie A, Daily P, Veazey R, Lackner A, et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nature Med 1996; 2:1984-1989. This controlled simian experiment provides compelling biological evidence to support the increased likelihood of SIV transmission associated with progesterone use.
11. O'Brien T, Winkler C, Dean M, Nelson J, Carrington M, Michael N, White G. HIV-1 infection in a man homozygous for CCR532 [letter]. Lancet 1997; 349:1219.
12. Theodorous I, Meyer L, Magierowska M, Katlama C, Rouzioux C, and the Seroco Study Group. HIV infection in an individual homozygous for CCR532. Lancet 1997; 349:1219-1220.
13. Balotta C, Bagnarelli M, Violin A, Ridolfo D, Zhou A, Berlusconi S, et al. Homozygous Δ32 deletion of the CCR-5 chemokine receptor gene in an HIV-1 infected patient. AIDS 1997; 11:F67-F71.
14. Wu L, Paxton W, Kassam N, Ruffing N, Rottman J, Sullivan N, et al. CCR5 levels and expression patterns correlate with infectability by macrophage-tropic HIV-1 in vitro. J Exp Med 1997; 185:1681-1691.
15. Samson M, Libert F, Doranz B, Rucker J, Liesnard C, Farber C, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR5 chemokine receptor gene. Nature 1996; 382:722-725.
16. O'Brien T, Padian N, Hidge T, Goedert J, O'Brien S, Carrington M. CCR5 genotype and sexual transmission of HIV-1. AIDS (in press).
17. Beretta A, Furci L, Burastero S, Cosma A, Dinelli M, Lopolco L, et al. HIV-1 specific immunity in persistently seronegative individuals at high risk for HIV infection. Immun Lett 1996; 51:39-43.
18. Zerhouni B, Touraine J. HIV-specific cytotoxic T lymphocytes in persons exposed through sexual contact with HIV-infected persons. J AIDS 1997; 15:172-173.
19. Fowke K, Nagelkerke J, Kimani J, Simonsen N, Anzala A, Bwayo J, et al. Resistance to HIV-I infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 1996; 348:1347-1351. One of the few prospective studies where HIV-resistant individuals were revealed over time while being followed under study protocols.
20. Cohen M, Hoffman I, Royce R, Kazembe P, Dyer J, Daly C, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. Lancet 1997; 349:1868-1873. The first study to provide direct evidence of both the effects of STDs (specifically gonorrhea) on viral load in semen, as well as the effect of STD treatment.
21. Ghys P, Fransen K, Diallo M, Ettegne-Traore I, Coulibaly K, Yerboue K, et al. The association between cervicovaginal HIV shedding in sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d'Ivoire. AIDS 1997; 11:F85-95. The first study to provide direct evidence of the effect of STDs on viral shedding in cervicovaginal secretions as well as the effect of STD treatment.
22. Operskalski E, Stram D, Busch M, Huang W, Harris M, Dietrich S, et al. Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Am J Epidemiol 1997; 146:655-662.
23. Vernazza P, Gilliam B, Flepp M, Dyer J, Frank S, Fiscus A, et al. Effect on antiviral treatment on the shedding of HIV-1 in semen. AIDS 1997; 11:1249-1255.
24. Garnett G, Anderson R. Antiviral therapy and the transmission dynamics of HIV-1. J Antimicrob Chemother 1996; 37 (suppl B): 135-150. Using statisical models, this paper provides an interesting review and analysis of the possible effect of the population-based use of antiviral drugs to reduce HIV transmission.
25. Centers for Disease Control. Case-control study of HIV seroconversion in health care workers after percutaneous exposure to HIV-infected blood- France, United Kingdom, and the United States. MMWR 1995; 44:929-933.
26. Katz M, Gerberding J. Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or infection drug use. N Engl J Med 1997; 336:1097-1100.
27. Hira S, Feldblum P, Kamanga J, Mukelabai G, Weir S, Thomas J. Condom and nonoxynol-9 use and the incidence of HIV infection in serodiscordant couples in Zambia, Int J STD AIDS 1997; 8:243-250.
28. Roddy R, Zekeng L, Kelley R, Tamouofe U, Weir S, Elie D, et al. A randomized controlled trial of the effect of nonoxynol-9 film use on male-to-female transmission of HIV-1. Abstract presented at the Third International Conference on HIV and Women; Los Angeles; 1997.